SMO variants explain the majority of drug resistance in basal cell carcinoma [RNA-Seq]
Direct links to NCBI, no account and no request form: the whole study as GSE58375_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 21 samples. Raw sequencing reads are also available from ENA.
Also filed as BioProject PRJNA252377 and SRA study SRP043085. Searching any of these in the dataset finder brings you back here.
The sample list for this study is not cached yet. Press Sort into groups and it will be fetched from NCBI.
+ 21 more — browse all 21 samples with per-sample file links →
- GSE273829 GABA promotes resistance to immunotherapy of patients with TLS-positive tumors [RNA-seq] 92 samples
- GSE285963 Transcriptome profile of hepatocellular carcinoma in patients with atezolizumab plus bevacizumab therapy. 84 samples
- GSE198315 Multiregional single-cell profiling reveals extensive field cancerization and an immunosuppressive microenvironment in oral squamous cell carcinoma 36 samples
- GSE317207 Transcriptomic profiling of human hepatocellular carcinoma biopsy samples using bulk RNA-seq 33 samples
- GSE319969 Spatial and Bulk Transcriptomic Profiling Defines the Molecular Evolution of Cutaneous Squamous Cell Carcinoma and Reveals Stage-Specific Biomarkers of Clinical Relevance [RNA-Seq] 24 samples
- GSE299340 Single-cell RNA sequencing reveals B cell-related immunosuppressive landscape and a potential suppressor in hepatocellular carcinoma 10 samples
- GSE314342 Genome-scale perturb-seq in primary human CD4+ T cells reveals genes regulating T cell programs and human immune traits. 577 samples
- GSE205672 Transcriptomes of human PBMCs and monocytes in sepsis patients 460 samples
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.